2.120USD0.00%Mkt Cap: 24.54M USDP/E: 212.00Last update: 2026-05-26
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar…
Industry Peers
Drug Manufacturers - Specialty & GenericIndicators:|
Key Statistics
Company
Market Cap24.54M USD
Enterprise Value20.83M USD
Revenue (TTM)3.35M USD
Gross Profit3.35M USD
Net Income (TTM)-569.00K USD
Revenue/Share0.2900 USD
Last Price2.120 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)212.00
P/E (Forward)6.03
PEG—
EV/EBITDA-14.80
EV/Revenue6.21
P/S7.28
P/B0.91
EPS (TTM)0.01
EPS (Forward)0.35
52W Range
0.980058% of range2.950
52W High2.950 USD
52W Low0.9800 USD
Profitability
Gross Margin100.00%
Oper. Margin-28.45%
EBITDA Margin-41.96%
Profit Margin-18.83%
ROE-2.12%
ROA-1.51%
Growth
Revenue Growth84.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.45M USD
CapEx (TTM)—
FCF Margin39.64%
FCF Yield5.42%
Net Debt-3.60M USD
Net Debt/EBITDA2.56
Balance Sheet
Debt/Equity0.23
Current Ratio3.11
Quick Ratio2.37
Book Value/Sh2.322 USD
Cash/Share0.7270 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateMay 9, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.11.57M
Float9.49M
Insiders7.45%
Institutions33.97%
Short Interest
Short Ratio2.4d
Short % Float0.68%
Short % Out.0.49%
Shares Short56.77K
Short (prev mo.)48.28K
Technical
SMA 502.101 (+0.9%)
SMA 2001.734 (+22.3%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)21.08K
Avg Vol (10d)18.28K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—